A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Clinical trial NCT06780410 · RECRUITING

Trial details

NCT number: NCT06780410
Sponsor: Gan & Lee Pharmaceuticals.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hyperlipidemia

Start date: 2024-12-20
Primary completion: 2025-10-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.